1. Kalteren WS, Verhagen EA, Mintzer JP, Bos AF, Kooi EMW. Anemia and red blood cell transfusions, cerebral oxygenation, brain injury and development, and neurodevelopmental outcome in preterm infants: a systematic review. Front Pediatr. 2021; 9:644462
2. Bain A, Blackburn S. Issues in transfusing preterm infants in the NICU. J Perinat Neonatal Nurs. 2004;18(2):170–184
3. Aher S, Malwatkar K, Kadam S. Neonatal anemia. Semin Fetal Neonatal Med. 2008;13(4):239–247
4. Letterio J, Pateva I, Petrosiute A, Ahuja S. Hematologic and oncologic problems in the fetus and neonate. In: Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin’s Neonatal-Perinatal Medicine, 2-Volume Set: Diseases of the Fetus and Infant. 11th ed. Philadelphia, PA: Elsevier; 2019:1416–1503
5. Palis J. Primitive and definitive erythropoiesis in mammals. Front Physiol. 2014; 5:3
6. Otto CN. Hemoglobin metabolism. In: Keohane EM, Otto CN, Walenga JM, eds. Rodak’s Hematology: Clinical Principles and Applications. 6th ed. Philadelphia, PA: Elsevier; 2020: 91–103
7. Farid Y, Bowman NS, Lecat P. Biochemistry, hemoglobin synthesis. In: StatPearls. Treasure Island, FL: Stat Pearls Publishing; 2022.
Available at: https://www.ncbi.nlm.nih.gov/books/NBK536912/Accessed September 11, 2022
8. Butina M. Erythrocyte production and destruction. In: Keohane EM, Otto CN, Walenga JM, eds. Rodak’s Hematology: Clinical Principles and Applications. 6th ed. Philadelphia, PA: Elsevier; 2020:62–77
9. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res. 2009;668(1-2):4–10
10. Elghetany MT, Punia JN, Marcogliese AN. Inherited bone marrow failure syndromes. Clin Lab Med. 2021;41(3):417–431
11. Lo C, Glader B, Sakamoto KM. Bone marrow failure. In: Keohane EM, Otto CN, Walenga JM, eds. Rodak’s Hematology: Clinical Principles and Applications. 6th ed. Philadelphia, PA: Elsevier; 2020:299–315
12. Kim HY, Kim HJ, Kim SH. Genetics and genomics of bone marrow failure syndrome. Blood Res. 2022;57(S1): S86–S92
13. Shwachman H, Diamond LK, Oski FA, Khaw KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr. 1964; 65:645–663
14. OMIM. # 260400: Shwachman-Diamond syndrome 1; SDS1. 2022. Available at: https://www.omim.org/entry/260400. Accessed September 11, 2022
15. OMIM. # 617941: Shwachman-Diamond syndrome 2; SDS2. 2022. Available at: https://www.omim.org/entry/617941. Accessed September 11, 2022
16. Bezzerri V, Cipolli M. Shwachman-diamond syndrome: molecular mechanisms and current perspectives. Mol Diagn Ther. 2019;23(2): 281–290
17. Nelson AS, Myers KC. Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome. Hematol Oncol Clin North Am. 2018;32(4):687–700
18. Nelson A, Myers K. Shwachman-Diamond syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al, eds. Gene Reviews VR. University of Washington, Seattle; 1993. Available at: https://www.ncbi.nlm.
nih.gov/books/NBK1756/. Accessed September 11, 2022
19. Saito-Benz M, Miller HE, Berry MJ. Shwachman-Diamond syndrome (SDS) in a preterm neonate. J Paediatr Child Health. 2015;51(12):1228–1231
20. Black LV, Soltau T, Kelly DR, Berkow RL. Shwachman-Diamond syndrome presenting in a premature infant as pancytopenia. Pediatr Blood Cancer. 2008;51(1):123–124
21. Todorovic-Guid M, Krajnc O, Marcun Varda N, et al. A case of Shwachman-Diamond syndrome in a male neonate. Acta Paediatr. 2006;95(7):892–893
22. Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am. 2009;23(2):233–248
23. Cipolli M, Tridello G, Micheletto A, et al. Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old. BMJ Open. 2019;9(1): e022617
24. Toriello HV. Thrombocytopenia absent radius syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. Gene Reviews VR. University of Washington, Seattle; 1993. Available at: https://www.
ncbi.nlm.nih.gov/books/NBK23758/. Accessed September 11, 2022
25. OMIM. # 274000: Thrombocytopenia-absent radius syndrome; TAR. 2022. Available at: https://www.omim.org/entry/274000. Accessed September 11, 2022
26. Khincha PP, Savage SA. Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonatal Med. 2016; 21(1):57–65
27. Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009;145(2):164–172
28. Keohane EM. Thalassemias. In: Keohane EM, Otto CN, Walenga JM, eds. Rodak’s Hematology: Clinical Principles and Applications. 6th ed. Philadelphia, PA: Elsevier; 2020:424–444
29. Ali S, Mumtaz S, Shakir HA, et al. Current status of beta thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12)
30. Farashi S, Harteveld CL. Molecular basis of a-thalassemia. Blood Cells Mol Dis. 2018; 70:43–53
31. Forget BG, Bunn HF. Classification of the disorders of hemoglobin. Cold Spring Harb Perspect Med. 2013;3(2): a011684–a011684
32. Thom CS, Dickson CF, Gell DA, Weiss MJ. Hemoglobin variants: biochemical properties and clinical correlates. Cold Spring Harb Perspect Med. 2013;3(3): a011858
33. OMIM. # 603903: Sickle cell anemia. 2022. Available at: https://www.omim.org/entry/603903. Accessed September 11, 2022
34. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol Mech Dis. 2019;14(1):263–292
35. Randolph TR. Hemoglobinopathies (structural defects in hemoglobin). In: Keohane EM, Otto CN, Walenga JM, eds. Rodak’s Hematology: Clinical Principles and Applications. 6th ed. Philadelphia, PA: Elsevier; 2020:394–423
36. Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int. 2011;108(31-32):532–540
37. de Montalembert M. Sickle cell disease in the neonatal period [article in French]. J Gynecol Obstet Biol Reprod (Paris). 2004; 33(1 suppl): S12–S14
38. Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018; 4:18010
39. Monus T, Howell CM. Current and emerging treatments for sickle cell disease. JAAPA. 2019;32(9):1–5
40. Freommel C. Newborn screening for sickle cell disease and other hemoglobinopathies: a short review on classical laboratory methods—isoelectric focusing, HPLC, and capillary electrophoresis. IJNS. 2018;4(4):39
41. Camaschella C. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Semin Hematol. 2009;46(4):371–377
42. Cooley TB. A severe type of hereditary anemia with elliptocytosis: interesting sequence of splenectomy. Am J Med Sci. 1945; 209:561
43. Donker AE, Raymakers RA, Nieuwenhuis HK, et al. X-linked sideroblastic anaemia due to ALAS2 mutations in the Netherlands: a disease in disguise. Neth J Med. 2014;72(4):210–217
44. Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128(3):164–177
45. Fujiwara T, Harigae H. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia. Free Radic Biol Med. 2019; 133:179–185
46. Mendez M, Moreno-Carralero MI, Morado-Arias M, et al. Sideroblastic anemia: functional study of two novel missense mutations in ALAS2. Mol Genet Genomic Med. 2016;4(3):273–282
47. Aivado M, Gattermann N, Rong A, et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis. 2006;37(1):40–45
48. May A, Bishop DF. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica. 1998;83(1):56–70
49. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979; 95(6):976–984
50. Farruggia P, Di Marco F, Dufour C. Pearson syndrome. Expert Rev Hematol. 2018;11(3):239–246
51. Rotig A, Colonna M, Bonnefont JP, et al. Mitochondrial DNA deletion in Pearson’s marrow/pancreas syndrome. Lancet. 1989; 1(8643):902–903
52. Khasawneh R, Alsokhni H, Alzghoul B, et al. A novel mitochondrial DNA deletion in patient with Pearson syndrome. Med Arch. 2018;72(2):148–150
53. Pronman L, Rondinelli M, Burkardt DD, et al. Pearson syndrome: a rare cause of failure to thrive in infants. Clin Pediatr (Phila). 2019;58(7):819–824
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.